Multimodal Approach for Recalcitrant Melasma Using Picosecond Laser and Topical JAK Inhibition: A Case Report

Read full text Summarise with VIRAT
Authors: Hasan KH A H A Ashkanani, Maryam AlZaabi, Abdulaziz Alrasheed, Wael Aldaraji
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Melasma is a chronic hyperpigmentation disorder with high relapse rates, particularly in Fitzpatrick skin types III-V. Increasing evidence implicates cytokine-driven inflammation and visible light-induced melanogenesis as key contributors to disease persistence. These mechanisms support the rationale for exploring a multimodal therapeutic approach. CASE PRESENTATION: A woman in her early 30s with phototype IV presented with a 5-year history of recalcitrant centrofacial melasma. Previous treatments-including hydroquinone, oral tranexamic acid, and superficial chemical peels-produced only transient and incomplete improvement. Baseline Melasma Severity Index (MSI) score was 7.9, consistent with moderate-to-severe disease. INTERVENTION: Treatment consisted of low-fluence picosecond 755 nm alexandrite laser, short-term topical corticosteroid post-procedure, initiation of topical tofacitinib 2% cream twice daily for 11 months, and continuous iron oxide-based visible light-blocking photoprotection. Laboratory monitoring during therapy remained normal. OUTCOME: At 11 months, the patient achieved near-total clearance with an MSI reduction from 7.9 to 0.10 (98.7% improvement). No adverse events, post-inflammatory hyperpigmentation, or relapse were observed, including 3 months after treatment cessation. CONCLUSION: This case illustrates the potential clinical value of combining pigment-targeted picosecond laser therapy with topical JAK inhibition and visible light-specific photoprotection for recalcitrant melasma. The durable remission achieved supports further investigation into anti-inflammatory and photoreactive pathway modulation as adjunctive strategies in melasma management.

Fields of Study & Subjects

Dermatologic Treatments and Research melanin and skin pigmentation Cutaneous Melanoma Detection and Management

Publication details

Journal / source
Journal of Cosmetic Dermatology
Volume
25
Issue
4
Pages
e70783–e70783
Publication date
25 March 2026
Language
EN